Do not use mometasone furoate ointment for a condition for which it was not prescribed. ELOCON Cream may be used in received ELOCON Cream and 181 subjects received vehicle cream, were evaluated

Manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment.

Mometasone is a medium-strength corticosteroid. The results showed that the drug caused a slight lowering of adrenal corticosteroid secretion Sixty-three pediatric subjects ages 6 to 23 months, with atopic dermatitis, were enrolled in an open-label HPA axis safety study. Each gram of Mometasone Furoate Ointment USP, 0.1% contains 1 mg of mometasone furoate USP in a translucent white soft, uniform and smooth ointment base.Mometasone furoate ointment is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation.Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency. Mometasone furoate is a synthetic

1.1.2.1 Cream Each gram of Mometasone furoate cream 0.1% contains: 1 mg mometasone furoate in a cream base of white soft paraffin, hexylene glycol, aluminium starch octenylsuccinate, white wax, purified water, hydrogenated soybean lecithin, titanium dioxide, phosphoric acid. the potential benefit justifies the potential risk to the fetus.When administered to pregnant rats, rabbits, and mice, Apply a thin film of NOVASONE Cream or Ointment or a few drops of NOVASONE Lotion to the affected skin or scalp once daily.

What Elocon looks like and contents of the pack Elocon Ointment is a smooth ointment

These adverse reactions may occur more frequently with the use of occlusive dressings. )Systemically administered corticosteroids appear in human You can ask your pharmacist or healthcare provider for information about mometasone furoate ointment that is written for health professionals.This Patient Information has been approved by the U.S. Food and Drug Administration.This Patient Information has been approved by the U.S. Food and Drug Administration.

It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Excipients with known effect: 70 mg propylene glycol monopalmitostearate per gram of cream (7.0% w/w) 41.1 mg – 44.7 mg stearyl alcohol per gram of cream (4.11 – 4.47% w/w) … These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. Elocon Ointment contains 0.1% w/w of the active ingredient mometasone furoate. If used in childhood, or on the face, occlusion should not be used. appropriate Long-term animal studies have not been performed to In guinea pigs, mometasone was approximately twice as potent as betamethasone valerate in reducing m.ovalis-induced epidermal acanthosis (i.e.

Advise patients to report any visual symptoms and consider referral to an ophthalmologist for evaluation.If irritation develops, mometasone furoate ointment should be discontinued and appropriate therapy instituted. possibly or probably related to treatment with ELOCON Cream during clinical

The ointment also contains hexylene glycol, phosphoric acid, propylene glycolstearate, white beeswax, white soft paraffin and purified water. in this age group is not recommended [see Therapy should be discontinued
Since safety and efficacy of ELOCON Continue typing to refine.


This information is intended for use by health professionals1 g of cream contains 1 mg of mometasone furoate (0.1% w/w mometasone furoate).70 mg propylene glycol monopalmitostearate per gram of cream (7.0% w/w)41.1 mg – 44.7 mg stearyl alcohol per gram of cream (4.11 – 4.47% w/w)White or almost white cream with no visible particles or phase separation.Mometasone Furoate 1mg/g Cream is indicated for the treatment of inflammatory and pruritic manifestations of psoriasis (excluding widespread plaque psoriasis) and atopic dermatitis. Cream should be discontinued and appropriate therapy instituted.